CompanyNasdaqBurlington, MA
Bone Biologics Corp
Bone Biologics develops NELL-1 protein-based bone graft substitutes for bone regeneration in spinal fusion, trauma, and osteoporosis.
8-KSep 29Latest SEC filing
Form DNov 29$729K sold
July 2026
Sign inSign inBone Biologics develops NELL-1 protein-based bone graft substitutes for bone regeneration in spinal fusion, trauma, and osteoporosis.